The most advanced form of this condition is called geographic atrophy (GA), in which some retinal cells die off. The condition takes its name from the patches of damage on the retina, which can be ...

Among patients diagnosed with intermediate-stage age-related macular degeneration, a fair number of eyes in a new analysis showed evidence of geographic atrophy (GA), a leading cause of blindness.

Geographic atrophy is an advanced form of dry age-related macular degeneration that causes vision loss in older adults. Until recently, there were no treatments available to target the root cause.

Astellas has shored up the competitive profile of Izervay as a treatment for eye disorder geographic atrophy (GA), getting FDA approval for an extended treatment duration. The US regulator turned ...

Unless you’ve already been diagnosed with geographic atrophy , there’s a good chance you’ve never heard of it. And yet, the ...

A post-hoc analysis assessed micronutrient supplementation, including lutein and zeaxanthin, to determine if it slows progression of noncentral geographic atrophy. Share on Facebook. Opens in a ...

The phase 1b trial will enrol patients with geographic atrophy secondary to age-related macular degeneration (AMD), a leading cause of blindness. While there are multiple therapies available for ...

The companies have successfully executed all milestones to date. About Geographic Atrophy (GA) GA is a chronic, progressive and irreversible retinal disease that occurs in people with late-stage ...

a multifunctional modifier gene therapy for the treatment of geographic atrophy or GA secondary to dry age-related macular degeneration or dAMD. The Phase 2 trial enrolled 51 subjects who were ...

Astellas said the Ministry of Health, Labour and Welfare will evaluate ACP as a potential first treatment for patients with geographic atrophy. The company will also evaluate secondary to age ...